- Record: found
- Abstract: not found
- Article: not found
65—RXDX-106 Is an orally-available, potent and selective TAM/MET inhibitor demonstrating preclinical efficacy in MET-dependent human malignancies
E Lew, E. Tindall, A Franovic, A.E. Schairer, S Uryu, J. OH, M.D Falk, E. MARTIN, Y. Yokoyama, G.G. Li
2016
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.